Literature DB >> 1871693

Erythropoietin concentrations in obstructive sleep apnoea.

J M Goldman1, R M Ireland, M Berthon-Jones, R R Grunstein, C E Sullivan, J C Biggs.   

Abstract

Eight patients with obstructive sleep apnoea and a normal haemoglobin concentration underwent nocturnal studies during which oxyhaemoglobin saturation was recorded continuously with an ear oximeter and serum erythropoietin concentration was measured hourly by means of a radioimmunoassay. Serum erythropoietin concentrations remained within the normal range throughout the study despite falls in oxyhaemaglobin saturation in individuals to 33-78%. There was no relation between the degree of nocturnal hypoxaemia and serum erythropoietin concentrations. The brief cyclical episodes of hypoxaemia typical of obstructive sleep apnoea may not be a sufficient stimulus for erythropoietin secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871693      PMCID: PMC1020909          DOI: 10.1136/thx.46.1.25

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Serum erythropoietin in humans at high altitude and its relation to plasma renin.

Authors:  J S Milledge; P M Cotes
Journal:  J Appl Physiol (1985)       Date:  1985-08

2.  Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with chronic lung disease.

Authors:  M E Miller; J F Garcia; R A Cohen; E P Cronkite; G Moccia; J Acevedo
Journal:  Br J Haematol       Date:  1981-10       Impact factor: 6.998

3.  Diurnal variation of serum immunomoreactive erythropoietin in a normal subject.

Authors:  P M Cotes; B Brozovic
Journal:  Clin Endocrinol (Oxf)       Date:  1982-10       Impact factor: 3.478

4.  Plasma erythropoietin in men and mice during acclimatization to different altitudes.

Authors:  P H Abbrecht; J K Littell
Journal:  J Appl Physiol       Date:  1972-01       Impact factor: 3.531

5.  Circadian rhythm of erythropoietin in human serum.

Authors:  L Wide; C Bengtsson; G Birgegård
Journal:  Br J Haematol       Date:  1989-05       Impact factor: 6.998

6.  Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia.

Authors:  J A Wedzicha; P M Cotes; D W Empey; A C Newland; J P Royston; R C Tam
Journal:  Clin Sci (Lond)       Date:  1985-10       Impact factor: 6.124

7.  Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale.

Authors:  P M Calverley; R J Leggett; L McElderry; D C Flenley
Journal:  Am Rev Respir Dis       Date:  1982-05

8.  Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

Authors:  J C Egrie; P M Cotes; J Lane; R E Gaines Das; R C Tam
Journal:  J Immunol Methods       Date:  1987-05-20       Impact factor: 2.303

9.  Sleep in chronic obstructive lung disease.

Authors:  D C Flenley
Journal:  Clin Chest Med       Date:  1985-12       Impact factor: 2.878

10.  Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy.

Authors:  R R Grunstein; D J Handelsman; S J Lawrence; C Blackwell; I D Caterson; C E Sullivan
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

  10 in total
  3 in total

1.  Obesity hypoventilation syndrome.

Authors:  Laila Al Dabal; Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

Review 2.  Sleep-related breathing disorders. 4. Consequences of sleep disordered breathing.

Authors:  K A Ferguson; J A Fleetham
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction.

Authors:  Wojciech Kukwa; Renata Glowczynska; Krzysztof J Filipiak; Andrzej Kukwa; Grzegorz Opolski; Anna Budaj-Fidecka; Marcin Grabowski; Adam Galazka; Antoni Krzeski; Monika Kuzminska; Anna M Czarnecka
Journal:  Sleep Breath       Date:  2013-01-23       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.